In 2010 Beximco Pharma introduced 27 new generics in a total of 34 presentations,

which include seven ophthalmic drops, three !" asthma inhalers and also drugs
in categories such as, three cardiovascular, two multivitamins, two
musculos#eletal, two anti$infective, and one anti$dia%etic, among others&
'he three !"$%ased inhalers which were launched for the first time in
Bangladesh in 2010& "lso introduce for first time into the mar#et was a formulation
of Paracetamol (() mg& *apa +xtend&
Baximco Pharma,s -rowth prospects remain excellent with #e. %loc#%uster
products such as *apa and *eoceptin$/ in its portfolio&
In 2010 *apa and *eoceptin / ran#ed 2nd and 4th respectivel. on the national 0'op
!ive1 list& 2ore over ten of BP3,s %rands have annual sales in excess of B4' 100
million each&
92anagement "ccounting Practice "t Beximco Pharmaceuticals 3td5 " /eview 6f 7osting !unction
Block Buster product: *apa ighest selling drug in Bangladesh
pharmaceutical mar#et in terms of unit&
*eoceptin$/ ighest selling drug in Bangladesh
pharmaceutical mar#et in terms of value&
Bextrum8Bextrum -old +merged as the most admired and highest
selling nutritional supplement in
Bangladesh 2ar#et in 9ust one .ear&
"mdocal ighest selling cardiovascular drug in B4
in terms of value&
'ofen ighest selling oral anti$asthma drug in B4
in terms of value&
":masol ighest selling mastered dose inhaler in
Bangladesh in terms of value&
2.1.7 International Market:
Beximco Pharma continues to explore export opportunities and to reinforce its
footprint on a glo%al scale, which currentl. covers five different continents&
"longside the continuous endeavour to strengthen the position in existing mar#ets,
BP3 attempts to achieve d.namic growth worldwide&
Beximco Pharma commenced its international operations with the export of "PI to
ong ;ong in 1<<2 and formulation products to /ussia in 1<<3& 'he compan. has
received the =*ational +xport 'roph., >-old? for an impressive three times& @ince
then, BP3 has ta#en greater strides over the .ears to increase its footprints in
international mar#ets&
In 2010, BP3 successfull. ventured into several new countries including @outh
"frica >via contract manufacturing? and *etherlands "ntilles, and registered 4)
products in overseas mar#ets& 'he compan. achieved export revenues of '# 330&)4
million, up 21&47A over 200<&
'he current expansion of this overseas portfolio includes prioriti:ing and
directing mar#eting operations to focus more on highl. regulated mar#ets such
as the +uropean Bnion >+B?, B@", "ustralia and -77 mem%er countries for
value added generics&